NAM
MIRM icon

NorthCrest Asset Manangement’s Mirum Pharmaceuticals MIRM Stock Holding History

NorthCrest Asset Manangement’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$691K Buy
5,414
+33
+0.6% +$3.31K 0.02% 467
2026
Q1 		$507K Buy
5,381
+12
+0.2% +$1.13K 0.02% 469
2025
Q4 		$406K Buy
+5,369
New +$385K 0.01% 601

Other funds holding MIRM

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

NorthCrest Asset Manangement's MIRM Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its Mirum Pharmaceuticals (MIRM) stake by 0.61% in Q2 2026, buying an estimated $3.31K and bringing the position to 5,414 shares worth $691K. The position accounts for 0.02% of the portfolio, ranked #467.

NorthCrest Asset Manangement first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. 22 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • NorthCrest Asset Manangement held 5,414 shares of Mirum Pharmaceuticals worth $691K as of Q2 2026.
  • NorthCrest Asset Manangement bought 33 Mirum Pharmaceuticals shares in Q2 2026, an estimated $3.31K.
  • Mirum Pharmaceuticals made up 0.02% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #467 holding.
  • NorthCrest Asset Manangement first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 22 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.